Clin2
NCT06721195Likely a fitRecruiting

Study of Euphoria from Remimazolam During GI Scopes

EuphoriaRemimazolam BesylateGastrointestinal Endoscopy

Part of Digestive system, Mental health clinical trials.

This trial studies a sedative called remimazolam and how it makes people feel during routine upper and lower GI scope procedures. It may help doctors understand which patients are more likely to feel a sense of euphoria (a feeling of intense happiness) from the medicine.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
305 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old.
  • You are scheduled for a routine, painless upper or lower GI endoscopy (like gastroscopy or colonoscopy) that is expected to take 30 minutes or less.
  • You are in good general health (ASA class 1 or 2).
  • Your BMI is between 18 and 28.
  • You do not have a history of certain psychiatric disorders or substance abuse.
  • You are not allergic to the sedative medicines used in the study (remimazolam, sufentanil, or benzodiazepines).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07707258Recruiting
Remimazolam with oliceridine for sedation in older adults during GI endoscopy

This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.

Shanghai, Shanghai Municipality
NCT07395596Recruiting· Phase 4
Remimazolam for Bronchoscopy in High-Risk Patients

This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.

Hangzhou, Zhejiang
NCT07002801Recruiting
Remimazolam and Esketamine for Older Adults Having Painless Stomach and Colon Scope

This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.

Harbin, Heilongjiang
NCT06258356Not yet recruiting
Remimazolam sedation for high-risk ERCP

This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.

NCT06614036Recruiting· Phase 4
Remimazolam vs. Midazolam for sedation during upper GI endoscopy

This study compares two different sedative medicines, remimazolam and midazolam, to see which works better for people having a routine upper GI endoscopy (a camera test to look at your stomach and esophagus). If you are scheduled for this procedure and need sedation, you may be able to join.

Apeldoorn, Gelderland
NCT06777758Recruiting· Phase 4
Comparing two sedatives for endoscopy procedures

This trial compares two sedative medications, Remimazolam and Propofol, to see which works better for upper GI endoscopy exams and treatments. The goal is to help doctors choose the best option for patients.

Kaohsiung City

Hear when a new Remimazolam Besylate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.